The interaction of alcoholic liver disease and hepatitis C

Hepato-Gastroenterology

Volumn 45, Issue 20, 1998, Pages 331-339

  Marsano, Luis S ^a   Peña, Luis R ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Alcoholic liver disease; Hepatitis C

Indexed keywords

RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; COMORBIDITY; DISEASE COURSE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REVIEW; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPATITIS C; HUMANS; INTERFERONS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; RISK FACTORS;

EID: 0031961075     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R, Rodes J: Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury [see comments]. Hepatology 1990; 12(6):1295-9.
2. Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, Buskell-Bales Z, Grossman CJ, Roselle GA et al: Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) [see comments]. Hepatology 1991; 14(4 Pt 1):581-9.
3. Bode JC, Biermann J, Kohse KP, Walker S, Bode C: High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction? Alcohol 1991; 26(2):111-4.
4. Brillanti S, Masci C, Siringo S, Di Febo G, Miglioli M, Barbara L: Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991; 13(3):347-50.
5. Caldwell SH, Jeffers LJ, Ditomaso A, Millar A, Clark RM, Rabassa A, Reddy KR, De Medina M, Schiff ER: Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991; 86(9):1219-23.
6. Noguchi O, Yamaoka K, Ikeda T, Tozuka S, Sakamoto S, Kanayama M, Uchida T: Clinicopathological analysis of alcoholic liver disease complicating chronic type C hepatitis. Liver 1991; 11(4):225-30.
7. Halimi C, Deny P, Gotheil C, Trinchet JC, Mal F, Scavizzi M, Beaugrand M: Pathogenesis of liver cirrhosis in alcoholic patients: histological evidence for hepatitis C virus responsibility. Liver 1991; 11(6):329-33.
8. Nalpas B, Thiers V, Pol S, Driss F, Thepot V, Berthelot P, Brechet C: Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 1992; 14(2-3):381-4.
9. Shiomi S, Kuroki T, Minamitani S, Ueda T, Nishiguchi S, Nakajima S, Seki S, Kobayashi K, Harihara S: Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 1992; 7(3):274-6.
10. Corrao G, Carle F, Lepore AR, Zepponi E, Galatola G, Di Orio F: Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: a case-control study. Eur J Epidemiol 1992; 8(5):634-639.
11. Zarski JP, Thelu MA, Moulin C, Rachail M, Seigneurin JM: Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status. J Hepatol 1993; 17(1):10-4.
12. Mendenhall CL, Moritz T, Rouster S, Roselle G, Polito A, Quan S, DiNelle RK: Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275. Am J Gastroenterol 1993; 88(7):1022-6.
13. Caldwell SH, Li X, Rourk RM, Millar A, Sosnowski KM, Sue M, Barritt AS, McCallum RW, Schiff ER: Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score [see comments]. Am J Gastroenterol 1993; 88(7):1016-21.
14. Rosman AS, Paronetto F, Galvin K, Williams RJ, Liebert CS: Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis. Arch Intern Med 1993; 153(8):965-9.
15. Fong TL, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH: Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994; 19(3):554-7.
16. Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, Mazzanti R, Buzzelli G, La Villa G et al: In-apparent hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 1994; 19(3):577-82.
17. Gonzalez Quintela A, Alende R, Aguilera A, Tome S, Gude F, Perez Becerra E, Torre A, Martinez Vazquez JM, Barrio E: [Hepatitis C virus antibodies in alcoholic patients]. Rev Clin Esp 1995; 195(6):367-72.
18. Bird GL, Tibbs CJ, Orton D, Hillan KJ, MacSween RN, Williams R, Mills PR: Does hepatitis C contribute to liver injury in alcohol abusers in the west of Scotland? Eur J Gastroenterol Hepatol 1995; 7(2):161-3.
19. Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, Shiomi S, Kobayashi K, Otani S, Hayashi N et al: Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis [see comments]. Ann Intern Med 1992; 116(1):21-5.
20. Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Sem Liver Dis 1995; 15:101-109.
21. Nishiguchi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, Sakurai M, Shikata T, Yamamoto S: Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14(6):985-9.
22. Shimizu S, Kiyosawa K, Sodeyama T, Tanaka E, Nakano M: High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan. J Gastroenterology Hepatology 1992; 7:30-35.
23. Alter MJ: Epidemiology of hepatitis C in the west. Sem Liver Dis 1995; 15:5-14.
24. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis [see comments]. Lancet 1989; 2(8670):1004-6.
25. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, Mizuhara Y, Hirakawa J, Nakajima H, Fujisawa K et al: Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88(1):39-43.
26. Farinati F, Fagiuoli S, De Maria N, Chiaramonte M, Aneloni V, Ongaro S, Salvagnini M, Naccarato R: Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features. J Hepatol 1992; 14(2-3):183-7.
27. Takase S, Takada N, Enomoto N, Yasuhara M, Takada A: Different types of chronic hepatitis in alcoholic patients: does chronic hepatitis induced by alcohol exist? Hepatology 1991; 13(5):876-81.
28. Bode JC, Alscher DM, Wisser H, Bode C: Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Alcohol Alcohol 1995; 30(1):97-103.
29. De la Vega J, Rodriguez M, Gonzalez M, Martinez A, Sotorrio NG, Fernandez E, Rodrigo L: HCV infection in alcoholics with liver disease. J Hepatology 1993; 18(Suppl. 1):S184.
30. Goldberg SJ, Mendenhall CL, Connell AM, Chedid A: Non-alcoholic chronic hepatitis in the alcoholic. Gastroenterology 1977; 72(4Pt 1):598-604.
31. Levin DM, Baker AL, Riddell RH, Rochman H, Boyer JL: Non-alcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 1979; 66(3):429-34.
32. Crapper RM, Bathal PS, Mackay IR: Chronic active hepatitis in alcoholic patients. Liver 1983; 3:327-337.
33. Takase S, Takada N, Sawada M, Tsutsumi M, Takada A: Relationship between alcoholic liver disease and HCV infection. Alcohol Alcohol Suppl 1993; 1A:77-84.
34. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A: The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993; 17(1):9-13.
35. Wands JR, Carter EA, Bucher NL, Isselbacher KJ: Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 1979; 77(3):528-31.
36. Duguay L, Coutu D, Hetu C, Joly JG: Inhibition of liver regeneration by chronic alcohol administration. Gut 1982; 23(1):8-13.
37. Sawada M, Takada A, Takase S, Takada N: Effects of alcohol on the replication of hepatitis C virus. Alcohol Alcohol Suppl 1993; 1B:85-90.
38. Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Katayama K, Fusamoto H, Kamada T: Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 20(5):1115-20.
39. Shindo, M, Di Bisceglie, AM, Hoofnagle, JH: Long-term follow-up of patients with chronic hepatitis C treated with alfa-interferon. Hepatology 1992; 15:1013-1016.
40. Davis GL, Balart L, Schiff ER et al: Treatment of chronic hepatitis C with recombinant alpha interferon alfa. N Engl J Med 1989; 321:1501-1510.
41. Hoofnagle JH, Mullen KD, Jones DB et al: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986; 315:1575-1578.
42. Camps J, Crisostomo S, Garcia-Granero M et al: Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. Gut 1993; 34:1714-1717.
43. Saracco G, Rosina F, Torrani Cerenzia MR et al: A randomized controlled trail of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis. J Hep 1990; 11:S43-S49.
44. Reichard O, Foberg U, Fryden A et al: High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with Interferon-alfa 2b for 60 weeks. Hepatology 1994; 19:280-285.
45. Diodati G, Bonetti P, Noventa F et al: Treatment of chronic hepatitis C with recombinant human interferon-alfa 2a: results of a randomized controlled cinical trail. Hepatology 1994; 19:1-5.
46. Saracco G, Rosina F, Abate ML et al: Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alfa 2b. Hepatology 1993; 18:1300-1305.
47. Castillo I, Bartolome J, Navas S et al: Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. Hepatology 1994; 19:1342-1346.
48. Tsubota A, Chayama K, Ikeda K et al: Factors predictive of response to interferon-alfa therapy in hepatitis C virus infection. Hepatology 1994; 19:1088-1094.
49. Causse X, Godinot H, Chevallier M et al: Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterol 1991; 101:497-502.
50. Murakami CS, Wheeler D, Foster S et al: Histology and hepatic iron content predict response to interferon in chronic hepatitis C. AASLD Meeting, Chicago, 1995.
51. Neuschwander-Tetri AB, Jeffers LJ, Reddy KR, Bacon BR, Tzakis A, Webb M, Neri J, de Medina M, Viciana A, Schiff ER: Hepatic iron concentration (HIC) in end stage liver disease (ESLD) secondary to chronic hepatitis C (HCV) and/or alcoholic liver disease (ALD). AASLD Meeting, Chicago, 1995.
52. Okazaki T, Yoshihara H, Suzuki K, Yamada Y, Tsujimura T, Kawano K, Yamada Y, Abe H: Efficacy of interferon therapy in patients with chronic hepatitis C: comparison between non-drinkers and drinkers. Scand J Gastroenterol 1994; 29:1039-1043.
53. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB: Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996; 16(1):65-82.
54. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS: Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994; 20(3):410-5.
55. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessi C et al: Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 1994; 125(1):123-8.
56. Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR: Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995; 108(4):1104-9.
57. PF, Hoofnagle JH: Side effects of alpha interferon. Semin Liver Dis 1989; 9(4):273-7.
58. Adams F, Quesada JR, Gutterman JU: Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. Jama 1984; 252(7):938-41.
59. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, Jones EA: Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987; 147(9):1577-80.
60. Cooksley WGE, Crawford DHG, Foley PF, Lawford BR, Franz CP, Ritchie T, Noble EP: The D2 dopamine receptor A1 allele: a risk factor in hepatitis C infection? Hepatology 1995; 22:4.
61. Krawitt E, Wiesner R: Autoimmune Liver Disease. In: Zetterman R, editor. Autoimmune manifestations of alcoholic liver disease. New York: Raven Press; 1991. pp247-260.
62. Bell H: Association between HLA-BW40 and alcoholic liver disease with cirrhosis. Br Med J 1978; 822.
63. Perperas A, Tsantoulas D, Portmann B, Eddleston AL, Williams R: Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981; 22(2):149-52.
64. Niemela O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y: Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987; 7(6):1210-4.
65. Israel Y, Orrego H, Niemela O: Immune responses to alcohol metabolites: pathogenic and diagnostic implications. Semin Liver Dis 1988; 8(1):81-90.
66. Kanagasundaram N, Kakumu S, Chen T, Leevy CM: Alcoholic hyalin antigen (AHAg) and antibody (AHAb) in alcoholic hepatitis. Gastroenterology 1977; 73(6):1368-73.
67. Crossley IR, Neuberger J, Davis M, Williams R, Eddleston AL: Ethanol metabolism in the generation of new antigenic determinants on liver cells. Gut 1986; 27(2):186-9.
68. Neuberger J, Crossley IR, Saunders JB, Davis M, Portmann B, Eddleston AL, Williams R.: Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease. Gut 1984; 25(3):300-4.
69. Gluud C, Tage-Jensen U: Autoantibodies and immunoglobulins in alcoholic steatosis and cirrhosis. Acta Med Scand 1983; 214:61-66.